Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Does nitric oxide prevent oxidative mediated lung injury?

¹Department of Pediatric Research, The National Hospital, University of Oslo, Norway. o.d.saugstad@klinmed.uio.no

Acta Paediatrica (Oslo, Norway : 1992)

|September 8, 2000

Summary

Nitric oxide (NO) inhalation therapy is approved for term infants with hypoxic respiratory failure but has not reduced mortality. Further studies are needed to understand NO

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Critical Review of the 2025 International Liaison Committee on Resuscitation Treatment Recommendations for Resuscitating the Newly Born Infant.

Acta paediatrica (Oslo, Norway : 1992)·2026

Same author

Reduction in Perinatal Mortality after Implementation of HBB Training at a District Hospital in Mali.

Journal of tropical pediatrics·2019

Same author

Cerebellum Susceptibility to Neonatal Asphyxia: Possible Protective Effects of N-Acetylcysteine Amide.

Disease markers·2018

Same author

Assessment of cerebral perfusion with contrast-enhanced ultrasound during constriction of the neck mimicking malposition of the BD Odon Device™: a study in newborn piglets.

BJOG : an international journal of obstetrics and gynaecology·2017

Same author

Physical activity and the risk of preterm birth: a systematic review and meta-analysis of epidemiological studies.

BJOG : an international journal of obstetrics and gynaecology·2017

Same author

The fetal circulation, pathophysiology of hypoxemic respiratory failure and pulmonary hypertension in neonates, and the role of oxygen therapy.

Journal of perinatology : official journal of the California Perinatal Association·2016

Area of Science:

Neonatal medicine
Pulmonary hypertension
Oxidative stress

Background:

Nitric oxide (NO) inhalation therapy is FDA-approved for term infants (>34 wk gestation) with hypoxic respiratory failure and pulmonary hypertension.
While reducing the need for extracorporeal membrane oxygenation, NO therapy has not improved mortality rates in clinical trials.
Emerging evidence suggests NO can act as both an antioxidant and a prooxidant, influenced by concentration and other factors.

Purpose of the Study:

To investigate the dual antioxidant/prooxidant effects of nitric oxide (NO) in a preclinical model.
To explore the relationship between NO, oxidative stress, inflammation, and apoptosis.
To highlight the need for long-term follow-up studies in infants receiving NO inhalation therapy.

Main Methods:

Evaluation of nitric oxide (NO) effects on Wistar rat lungs, assessing free radical-mediated injury.
Investigation of NO's interaction with hyperoxia to determine its impact on oxidative stress.
Review of recent findings on NO's role as a second messenger in cytokine activation and apoptosis.

Main Results:

High-dose nitric oxide (NO) induced free radical-mediated lung injury in rats.
In combination with hyperoxia, NO attenuated hyperoxic oxidative stress.
NO activates cytokines and induces apoptosis, suggesting a link to inflammation and growth regulation.

Conclusions:

Nitric oxide (NO) inhalation therapy presents potential short-term and long-term adverse effects.
The therapy remains experimental in premature infants, necessitating further clinical investigation.
Long-term follow-up studies are crucial to fully understand the consequences of NO inhalation therapy.

Related Experiment Videos